Winterflood Securities is delighted to announce the successful completion of its latest WRAP (Winterflood Retail Access Platform) Retail Offer with Arecor Therapeutics plc, raising £160k.
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying its proprietary technology platform, Arestat™, the company is developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Through the WRAP Retail Offer, Winterflood is pleased to connect the retail investing community with public listed companies and is delighted to be able to work with Arecor Therapeutics plc and Panmure Liberum on this successful fundraise.
To read more, please access the RNS here: WRAP Retail Offer. If you would like to discuss WRAP or this announcement in more detail, please contact Andrew Stancliffe, Head of Execution Services or Joe Winkley, Director & Head of Corporate Services at Winterflood Securities Limited
